Giacomo Barchiesi

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Giulia Bon, Laura Pizzuti, Valentina Laquintana et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Teresa Gamucci, Laura Pizzuti, Clara Natoli et al. · Cancer Biology & Therapy · 2018 · 42 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +15

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

Morena Antonilli, Hassan Rahimi, Valeria Visconti et al. · International Journal of Oncology · 2016 · 39 citations · Full text

Medicine, Immunology, Oncology +17

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence

Eriseld Krasniqi, Laura Pizzuti, Giacomo Barchiesi et al. · Journal of Cellular Physiology · 2020 · 33 citations

Medicine, Oncology, Breast Oncology +15

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

S Caponnetto, Giovanni Maria Iannantuono, Giacomo Barchiesi et al. · Oncology · 2017 · 18 citations

Medicine, Immunology, Oncology +15